Warning letter
Jiangmen Shuizirun Sanitary Articles Co., Ltd.: warning letter of Sep 23, 2026
FDA warning letter 722974 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 722974 |
|---|---|
| Company | Jiangmen Shuizirun Sanitary Articles Co., Ltd. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Sep 23, 2026 |
| Posted date | Oct 13, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211, 211.22, 211.34, 211.84(d)(1), 211.100(a), 211.100(b), 211.113(b), 211.130(c), 211.165(a), 211.166 |
| Inspection city | Jiang Men |
| Inspection start date | Nov 3, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: